If you’re looking for a solid pair of true wireless earbuds under Rs. 5,000, three options stand out in 2025: Realme Buds T310 vs OnePlus Buds 3 vs OnePlus Nord Buds 3. Each offers active noise cancellation (ANC), big battery life, and modern features like Bluetooth 5.3/5.4 and fast charging, but they cater to slightly different user needs.
Let’s break down the pros and cons of each so you can make the right choice.
Realme Buds T310: Budget ANC + Gaming Mode
Pros:
- Impressive 46 dB hybrid ANC at a budget price.
- Low latency (45 ms) for gaming.
- Long 40-hour battery life, with fast charging (10 min = 5 hrs).
- Spatial audio and dual-device pairing.
- Lightweight design, IP55 water/dust resistance.
Cons:
- No support for high-res codecs like LHDC or aptX.
- Mic quality is average, especially in noisy environments.
- Touch controls can occasionally misfire.
OnePlus Buds 3: Flagship Features Without Flagship Price
Pros:
- Dual drivers (woofer + tweeter) for rich, balanced sound.
- Adaptive ANC up to 49 dB, adjusts based on environment.
- LHDC codec support for OnePlus devices.
- Features like spatial audio, Audio ID 2.0, and multipoint pairing.
- 10 min fast charge = 7 hours playback.
Cons:
- No auto wear detection.
- Slightly bulky for smaller ears.
OnePlus Nord Buds 3: All-Rounder with Great Battery
Pros:
- 32 dB ANC, solid for daily use.
- BassWave EQ, Master EQ presets for audio customization.
- Best-in-class battery backup (up to 43 hrs).
- Dual-device pairing.
- IP55 water resistance.
Cons:
- Sound clarity isn’t as refined as Buds 3.
- No LHDC or aptX support.
- Mic performance dips in windy environments.
Verdict
That’s all about the Realme Buds T310 vs OnePlus Buds 3 vs OnePlus Nord Buds 3.
- Choose Realme Buds T310 if you want strong ANC, spatial audio, and gaming mode.
- Go for OnePlus Buds 3 if you prefer premium sound, powerful ANC, and advanced features.
- Pick OnePlus Nord Buds 3 if you want long battery life, decent ANC, and EQ control at a mid-budget price.
Compare earbuds to make a strong and informed buying decision.
